home / stock / oprx / oprx news


OPRX News and Press, OptimizeRx Corporation From 05/29/25

Stock Information

Company Name: OptimizeRx Corporation
Stock Symbol: OPRX
Market: NASDAQ
Website: optimizerx.com

Menu

OPRX OPRX Quote OPRX Short OPRX News OPRX Articles OPRX Message Board
Get OPRX Alerts

News, Short Squeeze, Breakout and More Instantly...

OPRX - (OPRX) Investment Analysis

2025-05-29 22:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

OPRX - OptimizeRx raises 2025 revenue guidance to $101M-$106M as subscription transition gains traction

2025-05-12 21:57:01 ET More on OptimizeRx OptimizeRx Corporation (OPRX) Q1 2025 Earnings Call Transcript OptimizeRx Corporation (OPRX) Q4 2024 Earnings Call Transcript OptimizeRx Q1 2025 Earnings Preview OptimizeRx beats top-line and bottom-line estimates; in...

OPRX - OptimizeRx Corporation (OPRX) Q1 2025 Earnings Call Transcript

2025-05-12 21:56:12 ET OptimizeRx Corporation (OPRX) Q1 2025 Earnings Conference Call May 12, 2025, 04:30 PM ET Company Participants Steve Silvestro - Chief Executive Officer Edward Stelmakh - Chief Financial Officer Andrew D'Silva - Senior Vice President, Corpor...

OPRX - OptimizeRx Non-GAAP EPS of $0.08 beats by $0.20, revenue of $21.9M beats by $3.21M

2025-05-12 17:03:51 ET More on OptimizeRx OptimizeRx Corporation (OPRX) Q4 2024 Earnings Call Transcript OptimizeRx Q1 2025 Earnings Preview OptimizeRx beats top-line and bottom-line estimates; initiates FY25 outlook Seeking Alpha’s Quant Rating on Opt...

OPRX - OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance

Q1 revenue of $21.9 million, increasing 11% year-over-year Q1 gross profit increased 9% year-over-year to $13.3 million Increases full year 2025 guidance to a revenue range between $101 million and $106 million and adjusted EBITDA range between $13 million and $15 million WAL...

OPRX - Expected US Company Earnings on Monday, May 12th, 2025

Redwire Corporation (RDW) is expected to report $-0.2 for Q1 2025 Organigram Global Inc. (OGI) is expected to report $-0.03 for Q2 2025 Inter & Co. Inc. (INTR) is expected to report $0.12 for Q1 2025 Pervasip Corp (PVSP) is expected to report for quarter end 2025-02-28 Maui La...

OPRX - OPRX - Historical Price Movements Surrounding Earnings

2025-05-11 18:48:13 ET OptimizeRx Corporation (OPRX) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 10.18%. The average open to low on the day of earnings was -6.82%. The average open t...

OPRX - OPRX - Historical Earnings Price Analysis

2025-05-11 18:43:14 ET OptimizeRx Corporation (OPRX) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in OPRX stock price following earnings has averaged ±13.66% , with a median of 10.53%....

OPRX - OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report

WALTHAM, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, has published its Environ...

OPRX - OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET

WALTHAM, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and patients, will hold a conferen...

Previous 10 Next 10